-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/iron-deficiency-anemia-in-renal-dialysis-patients
June 17, 2008 - None
Appropriateness for EHC Program
Does your question include a health care drug, intervention,
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/can-anything-be-done-to-improve-diabetic-periphheral-neuropathywhat-is-truly-effective-what-research-seems-promising-diabetes-type-2well-controlled
April 02, 2013 - Appropriateness for EHC Program
Does your question include a health care drug, intervention, device
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
January 31, 2013 - Additional devices designed to reduce restenosis (cryoplasty balloons,
cutting balloons, drug-eluting … balloons, and drug-eluting stents) are currently being evaluated in
RCTs. … What are the significant safety concerns associated with each treatment strategy
(e.g., adverse drug … What are the significant safety concerns associated with each treatment strategy
(e.g., adverse drug … What are the significant safety concerns associated with each treatment strategy
(e.g., adverse drug
-
effectivehealthcare.ahrq.gov/products/patient-outcomes-symposium/executive
May 03, 2012 - manuscripts for independent peer review and publication in a journal supplement of Pharmacoepidemiology and Drug … Pharmacoepidemiology and Drug Safety , Volume 21, Supplement 2, June 2012 .
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0399_01-07-2011.pdf
January 01, 2011 - brachytherapy, RE; D) liver-directed chemotherapy, including hepatic artery infusion
(HAI) chemotherapy, TACE, drug-eluting … brachytherapy, RE; D) liver-directed chemotherapy, including hepatic artery infusion
(HAI) chemotherapy, TACE, drug-eluting
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostatic-hyperplasia-medications_research-protocol.pdf
April 21, 2015 - In the early 1990s, the Federal Drug Administration (FDA) approval of medications for
BPH shifted LUTS … prostates with
either agent are supported by systematic reviews.10, 13
Recently, newer drugs and other drug … Common medications used to treat LUTS associated with BPH
Drug class -
Mechanism of action Medication … , drug manufacturer, device
trade name, keyword]
109. exp Product Surveillance, Postmarketing/
110 … . exp "Drug-Related Side Effects and Adverse Reactions"/
111. exp Adverse Drug Reaction Reporting Systems
-
effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
January 01, 2012 - similar drugs in the same class are read separately), and then topics in the same class of a
device, drug
-
effectivehealthcare.ahrq.gov/products/mental-illness-employment/abstract
December 20, 2011 - and somatic chronic care; and (3) patient-reported outcomes, including functional status, alcohol and drug
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/comparative-effectiveness-for-the-treatment-of-major-depressive-disorder-mdd-key-questions-1-for-the-treatment-of-mdd-what-is-the-comparative-effectiveness-of-ssris-placebo-psychotherapy-exercise-and-alternative-therapies-2-f
March 11, 2013 - Appropriateness for EHC Program
Does your question include a health care drug, intervention, device
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/please-help-find-something-to-ease-my-mothers-pain-with-restless-leg-syndrome-it-has-bothered-her-for-over-30-years-and-now-is-almost-unbearable-at-78-years-old-it-has-really-diminished-her-joy-in-life
January 06, 2010 - Appropriateness for EHC Program
Does your question include a health care drug, intervention, device
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-are-the-best-options-for-fertility-treatment-in-terms-of-safety-and-effectiveness
January 31, 2013 - None
Appropriateness for EHC Program
Does your question include a health care drug, intervention
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/is-there-an-easier-way-to-test-for-celiac-disease
March 11, 2012 - Appropriateness for EHC Program
Does your question include a health care drug, intervention, device
-
effectivehealthcare.ahrq.gov/products/dementia-databases-methods/research
May 22, 2008 - Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD. 2 Peter Lamy Center on Drug … settings was also found despite the different method of measuring medication use, with institutional drug … This relationship also held in the community, albeit overall rates of drug use were lower (15.5% versus … particularly important to replicate this work given that new drugs (specifically memantine) and other drug … The quality of antipsychotic drug prescribing in nursing homes.
-
effectivehealthcare.ahrq.gov/products/tinnitus/research
August 23, 2013 - Current Page Topic Timeline Feb. 17, 2012 Topic Suggestion Feb. 22, 2012 Research Protocol Aug. 23, 2013 Systematic Review Nov. 27, 2013 Disposition of Comments Report Evaluation and Treatment of Tinnitus: Comparative Effectiveness
Systematic Review Archived August 23, 2013 Web Version [NLM Site] Download Main Doc…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
November 01, 2012 - etanercept, and adalimumab), and
one anti-IL 12/23 agent (ustekinumab) have approval
from the Food and Drug … agents concluded a difference in efficacy, suggesting
heterogeneity within the class and indicating drug … and therefore do not make between-class
comparisons, rather limit comparisons with the individual
drug … systemic biologic
agents and systemic nonbiologic agents (between-class
comparisons on an individual drug … systemic biologic
agents and systemic nonbiologic agents (between-class
comparisons on an individual drug
-
effectivehealthcare.ahrq.gov/products/antidepressants-update/research-protocol
July 13, 2011 - relapse (i.e., continuation phase) or recurrence (i.e., maintenance phase) when a patient continues the drug … medications with new formulations (such as an extended release formulation) are approved by the Food and Drug … Administration (FDA) through an application called a supplemental new drug application (sNDA). … of interest is whether response or remission can be maintained if patients who have responded to one drug … If fewer than three head-to-head trials are available for any drug comparison, we will compute indirect
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
July 13, 2011 - , continuation phase) or recurrence (i.e.,
maintenance phase) when a patient
1) continues the drug … medications
with new formulations (such as an extended release formulation) are approved by the
Food and Drug … Administration (FDA) through an application called a supplemental new
drug application (sNDA). … interest is whether response or
remission can be maintained if patients who have responded to one drug … If fewer than three
head-to-head trials are available for any drug comparison, we will compute indirect
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1506.pdf
December 01, 2015 - similar drugs in the same class are read separately), and then topics in the same class of a
device, drug … study examining metadoxine for treating adult ADHD; a similar
trial is also planned to study this drug
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
December 01, 2014 - similar drugs in the same class are read separately), and then topics in the same class of a
device, drug … spontaneous preterm birth; interventions intended to target both
the pregnant woman and fetus (a drug
-
effectivehealthcare.ahrq.gov/products/cognitive-decline/research-2017
March 24, 2017 - Many interventions (e.g., nutraceuticals; one multimodal intervention using lifestyle advice and drug